Federica Sganga

Federica Sganga

Auto-generated profile, based on publicly available information

Federica Sganga

Department of Medical Sciences, Geriatric and Orthogeriatric Unit, S. Anna Hospital, Ferrara

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Geriatric Care
Verified
Journal Article
Open access
PDF file
SDSimone Dini
Simone Dini
FSFederica Sganga
Federica Sganga
MBMattia Brunori
Mattia Brunori
AVAurora Vitali
Aurora Vitali
APAnnalisa Paglia
Annalisa Paglia
GMGiulia Mussatti
Giulia Mussatti
Pneumonia is a very frequent problem for old frail patients due to diffusion, mortality, and other negative outcomes. The most complex aspects consist of the formulation of a diagnosis and the choice of an adequate treatment. In this context, optimal management requires the correct definition of the category and the most probable etiology involved in choosing the empiric treatment. Following this, it is crucial to conduct accurate examinations and, whenever feasible, switch to targeted treatments, ensuring timely adoption of oral administration.

2 April 2022 in International Journal of Palliative Nursing
Verified
Journal Article
Closed access
FSFederica Sganga
Federica Sganga
ASAndrea Salerno
Andrea Salerno
ABAlberto Borghetti
Alberto Borghetti
Massimo FantoniMassimo Fantoni
Massimo Fantoni
ATAdriana Turriziani
Adriana Turriziani
RBRoberto Bernabei
Roberto Bernabei
Aim: To analyse the presence and treatment of infections in hospitalised terminal patients by identifying potential risk factors. Methods: We conducted a retrospective study using health data from 229 terminally ill patients (evaluated by our hospital palliative care team (HPCT) hospitalised from January to December 2018. Results: A total of two types of infections were identified: blood flow infection (through blood cultures) and pneumonia (through radiological examinations), while the other cases of infection remained unknown. The most frequently identified microorganism was Staphylococcus spp. The prevalence of infections was higher in patients with non-oncological diseases (n=47, 36.7%; p value 0.009). The potential risk factors identified for infections were the presence of: Parkinson's disease (n=15, 11.7%; p value 0.005), dysphagia (n=49, 38.3%; p value 0.007), bedding (n=15, 11.7%; p value 0.048), pressure ulcers (n=31, 24. 2%); p value 0.018), oxygen therapy (n=60, 46.9%; p value 0.050), urinary catheters (n=95, 74.2%; p value 0.038) and polypathology (2.3 vs 1.7; p value 0.022). Parkinson's disease (OR=5.973; 95% CI=1.292-27.608), dysphagia (OR=2.090; 95% CI=1.080-4.046) and polypathology (OR=1.220; 95% CI=1.015-1.466) were confirmed by a corrected logistic regression analysis. Conclusions: Infections and, consequently, antibiotic therapies, have a high prevalence in hospitalised patients with terminal disease. Potential risk factors for infections in these patients could be polypathology, dysphagia and Parkinson's disease. Patients with these conditions could benefit from prevention programmes.